A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 45/06 (2006.01)
Patent
CA 2696271
The invention relates to a pharmaceutical composition according to claim 1 comprising a SGLT2 inhibitor in combination with a DPP IV inhibitor which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
La présente invention concerne une composition pharmaceutique contenant un inhibiteur SGLT2 en combinaison avec un inhibiteur DPP-IV, utilisable pour traiter ou prévenir une ou plusieurs affections choisies parmi le diabète de type 1, le diabète de type 2, une anomalie de la tolérance au glucose et l'hyperglycémie. En outre, la présente invention concerne des procédés pour prévenir ou traiter des troubles métaboliques et des affections apparentées.
Dugi Klaus
Himmelsbach Frank
Mark Michael
Boehringer Ingelheim International Gmbh
Fetherstonhaugh & Co.
LandOfFree
Pharmaceutical composition comprising a sglt2 inhibitor in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition comprising a sglt2 inhibitor in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition comprising a sglt2 inhibitor in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1771727